ANTIBODY FORMULATION
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent. La présente invention concerne des for...
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
19.12.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
La présente invention concerne des formulations pharmaceutiques à base d'une protéine de liaison à un antigène pharmaceutiquement active, par exemple de type anticorps monoclonal. Ces formulations comprennent, en plus de la protéine de liaison à un antigène, un agent tampon et un agent de tonicité. |
|---|---|
| AbstractList | The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
La présente invention concerne des formulations pharmaceutiques à base d'une protéine de liaison à un antigène pharmaceutiquement active, par exemple de type anticorps monoclonal. Ces formulations comprennent, en plus de la protéine de liaison à un antigène, un agent tampon et un agent de tonicité. |
| Author | MARSHALL, TRISTAN PERKINS, MELISSA D DUNLEAVY, DONNA M PURI, MANASI CROTTS, GEORGE H BLAKE-HASKINS, ANGELA O'BERRY, KRISTEN |
| Author_xml | – fullname: PURI, MANASI – fullname: DUNLEAVY, DONNA M – fullname: BLAKE-HASKINS, ANGELA – fullname: PERKINS, MELISSA D – fullname: CROTTS, GEORGE H – fullname: MARSHALL, TRISTAN – fullname: O'BERRY, KRISTEN |
| BookMark | eNrjYmDJy89L5WQQcfQL8XTyd4lUcPMP8g31cQzx9PfjYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzo5GliaWRoZGzsaEVQAA0sUfow |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | FORME PHARMACEUTIQUE A BASE D'ANTICORPS |
| ExternalDocumentID | CA2949212C |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA2949212C3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:55:17 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA2949212C3 |
| Notes | Application Number: CA20152949212 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231219&DB=EPODOC&CC=CA&NR=2949212C |
| ParticipantIDs | epo_espacenet_CA2949212C |
| PublicationCentury | 2000 |
| PublicationDate | 20231219 |
| PublicationDateYYYYMMDD | 2023-12-19 |
| PublicationDate_xml | – month: 12 year: 2023 text: 20231219 day: 19 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED |
| RelatedCompanies_xml | – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED |
| Score | 3.508271 |
| Snippet | The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | ANTIBODY FORMULATION |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231219&DB=EPODOC&locale=&CC=CA&NR=2949212C |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z06g33TTzewfDjQgDVnogBgpkGoHFMDNPC4UuepmLw_jv-9qAetmtaZOXvqa_99X3XgFuKS8Fmgm2PhayqbYwHN2lS7zLS8GdgjgjymXtcJKOJzP7ce7MO_DW1sKoPqHfqjkiIqpEvNdKXq__glihyq3c3PF3nPq4j3Mv1BrvGI0VicAw8KJpFmZMY8xjvpY-eyNqU5TSbAd20YgmEgvRSyBrUtb_FUp8BHtTpLWqj6EjVj04YO2_az3YT5rnbhw2yNv0oe-n-UOQha9DdNuS2ZMKLZ3ATRzlbKIj-cUvJwvmt_uwTqGL_r0YwNAyC9cklUEqm9tW6RbC4oIadlmQqiScnMFgG5Xz7UsXcCjPQ2ZemPQSuvXnl7hC_Vnza8X6D2A3cjo |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOJNQYOfcDDcFje20fWwGNZtGco2YobB07KOErwgkRn_fV-XTb1wa9rkpX3p7331vVeAe8pzgWaCoYyEbKotVFOx6Arv8kpwMyPmkHJZOxxGo2BuPC3MRQPWdS1M2Sf0u2yOiIjKEe9FKa-3f0Est8yt3D3wd5z6ePQT2x1U3jEaKxKBrmN7s9iN2YAxm40H0Ys9pAZFKc0O4BANbCKx4L06siZl-1-h-KdwNENam-IMGmLThhar_11rw3FYPXfjsELergOdcZRMnNh966PbFs6nZWjpHHq-l7BAQfLp70lSNq73oV9AE_170YW-rmWWRpYqWRrc0HMrEzoXVDXyjCxzwskldPdRudq_1INWkITTdDqJnq_hRPJGZmFo9AaaxeeXuEVdWvC7kg0_5Wt1LQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTIBODY+FORMULATION&rft.inventor=PURI%2C+MANASI&rft.inventor=DUNLEAVY%2C+DONNA+M&rft.inventor=BLAKE-HASKINS%2C+ANGELA&rft.inventor=PERKINS%2C+MELISSA+D&rft.inventor=CROTTS%2C+GEORGE+H&rft.inventor=MARSHALL%2C+TRISTAN&rft.inventor=O%27BERRY%2C+KRISTEN&rft.date=2023-12-19&rft.externalDBID=C&rft.externalDocID=CA2949212C |